The β-hydroxybutyrylation of Zyxin ameliorates pulmonary fibrosis by inhibiting lung fibroblast activation through the PI3K/AKT pathway
Li Qiu, Haoying Huang, Sen Li, Haixia Chen, Xiaohui Wang · 2026
Read The β-hydroxybutyrylation of Zyxin ameliorates pulmonary fibrosis by inhibiting lung fibroblast activation through the PI3K/AKT pathway by Li Qiu, Haoying Huang, Sen Li, Haixia Chen, Xiaohui Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13479915.txt.
Description
Li Qiu and four colleagues showed in 2026 how a tag on the protein Zyxin eases lung scarring in mice. Idiopathic pulmonary fibrosis is a lethal lung disease with murky causes, driven by overactive lung cells laying down excess scar tissue.
In bleomycin-injured mice, the Zyxin tag known as Kbhb fell sharply, while adding beta-hydroxybutyrate restored the tag and softened fibrosis. Gene and protein checks pointed to the PI3K/AKT pathway, with the tag lost at one Zyxin site in diseased mice. Removing Zyxin or giving the supplement cut scarring, collagen buildup, and death, marking this tag as a fresh treatment lead.
Catalog record
| CREATOR | Li Qiu, Haoying Huang, Sen Li, Haixia Chen, Xiaohui Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |